FDA Approves Its First Blood Test for Alzheimer's Disease, Pason Pharmaceuticals Facilitates Precision Diagnostic Breakthrough for Alzheimer's Disease！-News-PASON

News

FDA Approves Its First Blood Test for Alzheimer's Disease, Pason Pharmaceuticals Facilitates Precision Diagnostic Breakthrough for Alzheimer's Disease！

visits：167 source：

未标题-1.jpg

₁ Mayo Clinic Test Id : PT217 - Mayo Clinic Laboratories. https://www.mayocliniclabs.com/test-catalog/overview/621635.

₂Labcorp-Phosphorylated Tau 217 (pTau-217), Plasma TEST: 484390. https://www.labcorp.com/tests/484390/phosphorylated-tau-217-ptau-217-plasma.

Previous article：New diagnostic products in 2015 Next article：not have

In Vitro Diagnostic Products

Alzheimer's Disease INNO-LiPA HPV Genotyping INNO-LIA HCV Score INNO-LiPA HBV Genotyping INNO-LIA HIV I-II Score INNO-LIA Score INNO BIA Plasma Aβ Forms INNO LIA ANA Update INNO-LiPA HLA

Antibodies and Raw Materials

Antibodies

Instruments

Technical Support

News

News Qualifications

Phone：

010-68341662
010-68341663

Address：

Suite 303, Kai Xuan Da Sha, Jia143 Xi Zhi Men Wai Street, Xi Cheng District, Beijing 100044, PR China

Email：

info@pason-pharm.com